系统性硬化症自体造血干细胞移植中细胞因子释放综合征的发生率与特征
该回顾性研究分析了91例接受自体造血干细胞移植的系统性硬化症患者,按ASTCT标准对细胞因子释放综合征(CRS)分级,发现89.0%发生CRS,其中28.6%为2级、11.0%为3级、3.3%为4级、2.2%为5级(致死性)。2级及以上CRS中61.0%仅基于呼吸标准分级,未发现与2级及以上CRS显著相关的临床特征,总生存无显著差异。
要点
- 91例可分级患者中89.0%发生CRS,5级致死性CRS占2.2%。
- 2级及以上CRS占41例,其中61.0%仅依据呼吸标准分级。
- 未发现与2级及以上CRS显著相关的临床特征,总生存无显著差异。
核心结论
- CRS在接受自体HSCT的系统性硬化症患者中高度流行且具有临床相关性。
- 频繁的呼吸系统表现可能反映SSc相关心肺受累、血管病变及预处理液体负荷,而非单纯炎症,提示独特的CRS表型。
研究设计与样本
- 回顾性分析2011至2025年按(调整)ASTIS方案接受自体HSCT的SSc患者。
- CRS按美国移植与细胞治疗学会(ASTCT)标准分级。
- 探索CRS≥2与临床特征的关联,并用Kaplan-Meier分析评估总生存。
主要发现
- 41例CRS≥2患者中,61.0%仅基于呼吸标准分级。
- 多重检验校正后,未发现与CRS≥2显著相关的临床特征。
- 总生存无显著差异,尽管Kaplan-Meier曲线早期分离。
- 随访肺功能和皮肤评分在组间相似。
关键数值与推荐
- CRS分级采用ASTCT标准。
- CRS发生率89.0%,其中1级44.0%、2级28.6%、3级11.0%、4级3.3%、5级2.2%。
- CRS≥2中61.0%仅基于呼吸标准。
临床怎么用
- 接受自体HSCT的SSc患者应高度警惕CRS,尤其需关注呼吸系统表现。
- 呼吸标准在SSc患者CRS分级中占重要地位,需结合SSc相关心肺基础病变综合评估。
局限性
- 回顾性研究设计。
- 未报告样本量以外的多中心或单中心信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic sclerosis (SSc) is a debilitating autoimmune connective tissue disease associated with high morbidity and mortality. Autologous hematopoietic stem cell transplantation (HSCT) improves survival in diffuse cutaneous SSc. Cytokine release syndrome (CRS), a potentially fatal inflammatory response, is a complication of HSCT associated with anti-thymocyte globulin use. This study aimed to systematically describe the incidence and characteristics of ATG-related CRS in SSc patients undergoing HSCT. METHODS: SSc patients undergoing autologous HSCT according to the (adjusted) ASTIS protocol (2011-2025) were analysed retrospectively. CRS was graded according to American Society for Transplantation and Cellular Therapy (ASTCT) criteria. Associations between CRS ≥2 and clinical characteristics were explored, and overall survival was assessed using Kaplan-Meier analysis. RESULTS: Of the 91 eligible for grading, 81 (89.0%) were classified as having CRS: 40 (44.0%) as grade 1 (fever only), 26 (28.6%) as grade 2, ten (11.0%) as grade 3, three (3.3%) as grade 4, and two (2.2%) as grade 5 (fatal). Among the 41 patients with grade ≥2 CRS, grading was based solely on respiratory criteria in 61.0%. No significant associations with grade ≥2 CRS remained after multiple-testing correction. Overall survival did not differ significantly, although the Kaplan-Meier curves separated early. Follow-up lung function and skin scores were similar between groups. CONCLUSION: CRS is highly prevalent and clinically relevant in SSc patients undergoing autologous HSCT. The frequent respiratory manifestations may reflect SSc-related pre-existing cardiopulmonary involvement, vasculopathy, and fluid exposure during conditioning, rather than inflammation alone, suggesting a distinct CRS phenotype.
引用
- Schimmel CS, Hoekstra EM, Koops MF, et al. Incidence and characteristics of cytokine release syndrome in patients with systemic sclerosis undergoing autologous haematopoietic stem cell transplantation. Semin Arthritis Rheum. 2026. PMID: 42925737. doi:10.1016/j.semarthrit.2026.153087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。